NBTY Announces Agreement to Purchase Leiner Healt...(identified by the use ofterminology such...),Health

Date:6/10/2008

identified by the use of terminology such as "subject to," "believe," "expects," "plan," "project," "estimate," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. Although all of these forward looking statements are believed to be reasonable, they are inherently uncertain. Factors which may materially affect such forward-looking statements include: (i) slow or negative growth in the nutritional supplement industry; (ii) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest or disruption of mail service; (iii) adverse publicity regarding nutritional supplements; (iv) inability to retain customers of companies (or mailing lists) recently acquired; (v) increased competition; (vi) increased costs; (vii) loss or retirement of key members of management; (viii) increases in the cost of borrowings and/or unavailability of additional debt or equity capital; (ix) unavailability of, or inability to consummate, advantageous acquisitions in the future, including those that may be subject to bankruptcy approval or the inability of NBTY to integrate acquisitions into the mainstream of its business; (x) changes in general worldwide economic and political conditions in the markets in which NBTY may compete from time to time; (xi) the inability of NBTY to gain and/or hold market share of its wholesale and/or retail customers anywhere in the world; (xii) unavailability of electricity in certain geographical areas; (xiii) the inability of NBTY to obtain and/or renew insurance and/or the costs of the same; (xiv) exposure to and expense of defending and resolving product liability and intellectual property claims and other litigation; (xv) the ability of NBTY to successfully implement its business strategy; (xvi) the inability of NBTY to manage its retail, wholesale, manufacturing and other
'/>"/>

SOURCE NBTY, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. CorVel Announces Record Earnings
2. SUA Insurance Company Announces Partnership With American Safety Indemnity Company
3. WellPoint Announces Appearance at Upcoming Conference
4. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
5. Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer
6. Mylan Announces Final FDA Approval for Zaleplon Capsules
7. PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative
8. Senetek PLC Announces Key Personnel Appointments
9. QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million
10. Health Robotics Announces IV Station (TM Pending) a Centrally-Controlled,
11. Universal Health Realty Income Trust Announces Dividend Increase